Search

everythinglearnresearchcommunity

for

Search:↓

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

p63 is essential for controlling epithelial stem cells and tissue health.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.